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Diminished vascular response to noradrenaline in experimental
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Diminished vascular response to noradrenaline in experimental chronic
uremia. The vascular response to noradrenaline (NA) of the isolated
perfused hind limb, an index of resistance vessels, was studied in an
experimental model of chronic uremia (NX) in the rat. in this model of
NX, only a slight and insignificant rise in arterial BP was observed.
Plasma NA levels, but not adrenaline and dopamine levels, were
significantly elevated. At the same time, in an isolated, perfused heart
preparation, there was evidence for diminished neuronal uptake (NX
50.9 5.45 pmoles/min/heart; sham OP CO 85.1 13.5) and metabo-
lism in the presence of unchanged extraneuronal uptake and metabo-
lism of NA. Therefore, elevated plasma NA presumably represents an
overflow phenomenon. In the isolated perfused hind limb, despite a
lack of change in basal (no NA) and maximal (l0 M NA) resistance,
the dosage-response curve to NA was shifted to the right (EDS(, in NX
4.28 0.37 X 106 in sham OP CO 2.68 0.18). This constellation
suggests reduced NA sensitivity and argues against changed-vessel
geometry. A similar hyporesponsiveness (increased ED2() for NA) was
found in aortic strips. Nonspecific depression of the contractile appara-
tus of smooth vascular muscle is unlikely in view of increased vascular
response to depolarization with KCI and to BaCI2. Because the con-
strictor response to vasopressin was unchanged, subsensitivity was
specific for NA. Hyporesponsiveness to NA was not due to abnormal
uptake of NA in the vessel wall because it persisted in the presence of
blocked neuronal uptake (cocaine blockade). An imbalance of alpha and
beta receptors was excluded by the demonstration of persisting hypore-
sponsiveness after a beta blockade. Pretreatment of animals with
indomethacin (2 x I mg/day for 7 days) increased NA responsiveness in
NX animals. An insignificant difference was demonstrable between
indomethacin-treated CO and NX animals. One possible explanation of
the findings would be down-regulation of NA receptors in the presence
of elevated-circulating NA concentrations.
Diminution de Ia réponse vasculaire a Ia noradrénaline au cours de
l'urémie chronique expérimentale. La réponse vasculaire a Ia noradréna-
line (NA) du membre postérieur isolé et perfuse a été étudiée dans on
modèle d'urémie chronique (NX) chez Ic rat. Dans cc modéle du NX, il
n'a été observe qu'une augmentation faible et insignficative de Ia
pression artérielle. La concentration plasmatique de NA, mais pas
celles d'adrénaline et de dopamine, était significativement augmentee.
Dans les mémes conditions, dans une preparation de coeur isolé
perfuse, ii a etC observe une diminution de Ia captation neuronale (NX
50,9 5,45 pmoles/min/coeur; contrhle 85,1 13,5) et une diminution
do mCtabolisme neuronal alors que Ia captation et le métabolisme extra-
neuronaux ne sont pas modifies. L'augmentation de NA représente
probablement un phénomene de surproduction. Dans Ic membre poster-
ieur isolé et perfuse, malgré l'absence de modification de Ia résistance
basale (sans NA) et maximale (l0- si NA), Ia courbe dose-réponse a
NA est déplacée vers Ia droite (ED50 pour NX 4,28 0,37 x l0 M;
contrOles 2,68 0,18). Cette constatation suggCre one sensibilitC
diminuée a NA et plaide contre one modification de Ia geometric
vasculaire. Une diminution semblable de Ia réponse (ED2() augmentée) a
CtC constatée dans des lambeaux d'aorte. La depression non spCcifique
de l'appareil contractile du muscle vasculaire lisse est peu probable en
raison de l'augmentation de Ia rCponse vasculaire ala dCpolarisation par
KCI et BaCI2. La diminution de sensibilité est specifique pour NA
puisque Ia réponse vaso-constrictrice a Ia vasopressine est inchangee.
L'hypo-réaction a NA nest pas liCe a one captation anormale de NA
dans Ia paroi vasculaire puisqu'elIe persiste guand Ia captation neuron-
ale est bloquee (cocaIne). Un desequilibre des rCcepteurs alpha et beta
est exclu par Ia demonstration d'une hypo-reaction après blocage beta.
Le pré-traitement par l'indométhacine (2 x I mg/jour pendant 7 jours)
augmente Ia réactivité a NA chez les animaux NX. 11 n'est pas mis en
evidence de difference entre les contrôles traités par l'indométhacine et
les animaux NX. Une explication possible de ces observations serait
une regulation en baisse des récepteurs de NA en presence de concen-
trations circulantes ClevCes de NA.
Both in uremic patients and animals with experimental ure-
mia, abnormalities in the function of the sympathetic nervous
system have been reported, for example, disturbances of the
biosynthesis of catecholamines [I], reuptake of noradrenaline
(NA) [21, circulatory [3—4] and extracirculatory [5] sympathetic
actions, density of sympathetic innervation, as evaluated by
fluorescence microscopy [61, and so forth. Several investigators
[7—91 found elevated NA levels in uremic patients. Despite such
information, the role of the sympathetic nervous system in the
regulation of blood pressure (BP), or other autonomic func-
tions, of uremic patients is poorly defined. Whereas several
authors found unchanged responsiveness to NA or maneuvers
stimulating the sympathetic nervous system [10—12], others
concluded on the basis of indirect evidence that the vascular
response to NA was diminished [14].
The aim of our study is the analysis of end-organ responsive-
ness to noradrenaline in a model of isolated perfused resistance
vessels. The isolated hindlimb and aortic strips, that is, systems
devoid of reflex and humoral control, were chosen because they
permit direct analysis of the end-organ response. In addition,
circulating catecholamines, as well as noradrenaline uptake and
metabolism, were examined.
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Experimental protocol. Male Sprague-Dawley rats (200 to 250
g) were obtained from Ivanovas Company (Kisslegg/Allgau).
The animals were subjected to a dual-staged, subtotal nephrec-
tomy without irradiation of the remaining parenchyma as previ-
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ously described [14]. The animals were kept in single cages at a
constant temperature (22° C) and humidity (60%) with a 12-hr-
on—l2-hr-off light cycle. Control animals (CO) were sham-
operated (OP) (decapsulation of the kidney) and fed in pairs.
The animals received an Altromin diet (Altromin Company;
Lage/Lippe; catalogue number Cl000); with 17.6 g NaCl/kg dry
wt. The animals had free access to deionized water. The
experiment was terminated after 35 to 42 days of uremia.
In experiments with acute uremia (NX), animals were pre-
adapted to a low potassium diet (50 mmoles K/kg dry wt) for 2
days. The rats were not given food and water following a
bilateral nephrectomy; the experiment was performed 48 hr
after the operation.
In the study with parathyroidectomy, the parathyroids were
removed surgically with the use of an operating microscope.
Forty-eight hr after the operation, plasma calcium was mea-
sured. The animals used were only those in whom fasting
plasma calcium decreased by more than 0.75 mmoles/liter.
BP measurements. The systolic BP was measured under light
ether anesthesia by means of tail plethysmography [15]. In
addition, in a separate series of animals, BP was measured in
awakened nonstressed animals with the use of chronically
implanted catheters in the femoral artery as previously de-
scribed [161.
Analytical methods: Determination of plasma catechol-
amines. For determination of plasma noradrenaline (NA),
adrenaline and dopamine, blood (0.5 ml) was collected from an
incision in the tail under light thiobutabarbital anesthesia (Inac-
tin, 50 mg/kg), administered i.p. 30 mm before sampling. This
procedure was validated previously [171 by comparison with
blood obtained from awakened nonstressed animals with chron-
ically-implanted, femoral catheters. It was clearly demonstrat-
ed that the described procedure yielded basal catecholamine
values on a reproductive basis.
Blood was collected into cooled microtubes, containing 5 U
of heparin and immediately centrifuged at 0° C at 5000 g for 10
mm. To 200 il of plasma, 200 l of 0.6 N perchloric acid were
added. The mixture was centrifuged again under the same
conditions, and the supernatant was frozen and stored at
—30° C in aliquots of 100 1.d. Sample preparation with the
described protocol results in stability of catecholamine values
for several months. In each of the aliquots, NA, adrenaline and,
dopamine concentrations were determined radioenzymatically
[181 (catechol-O-methyl-transferase using the Axelrod and
Tomchick method of [19] methylation with S-adenosyl-methio-
nine3-H, extraction with ether in the presence of tetraphenyl-
borate, extraction with hydrochloric acid, and separation by
thin-layer chromatography). Before liquid scintillation count-
ing, the specificity was improved by oxidation of normetaneph-
rine and metanephrine to vanillin.
Plasma chemistry. Plasma chemistry (sodium, potassium,
calcium, and creatinine) was measured with an Autoanalyzer
(Technicon Company). For these determinations at the end of
the experiment, blood was drawn from the aorta.
NA uptake mechanisms in the isolated, perfused heart. The
activities of neuronal and extraneuronal uptake for NA were
determined in the isolated, perfused rat heart preparation using
Langendorif's method of perfusion with oxygenated modified
Tyrode® solution containing tritiated NA (I 0 moles/liter,
Amersham Company). The concentration of radioactive NA, its
deaminated metabolite (DOPEG = 3 ,4-dihydroxyphenylgly-
col), and its 0-methylated metabolites (NMN = normetaneph-
rine, VMA = 3-methoxy-4-hydroxymandelic acid, MOPEG =
3-methoxy-4-hydroxyphenylglycol) were measured in both per-
fusate and effluent, following a separation procedure described
by Graefe, Stefano, and Langer [20].
In an initial step the catechol compounds were adsorbed on
an A1203 column at pH 8.2. The 0-methylated metabolites,
found in the effluent, could be separated by a Dowex® SOW x 4
column into two fractions, one containing VMA and MOPEG
(effluent), the other containing NMN (6N HC1: ethanol eluate).
The compounds adsorbed on A1203 were eluated by 0.2 N acetic
acid (NA and DOPEG). NA and DOPEG were separated by
adsorption of NA on a Dowex® SOW x 4 column. DOPEG was
found in the effluent, whereas NA was eluated by 2N hydrogen
chloride. The fractional values obtained by liquid, scintillation
counting were corrected for quench, but not for recovery,
because recovery for NA and all metabolites was greater than
90%.
Uptake and metabolism rates were calculated from the arteri-
ovenous difference under steady, state conditions before and
after the blockade of neuronal uptake with cocaine (30 x 106
moles/liter) and after the additional blockade of the extraneur-
onal uptake with corticosterone (100 x 106 moles/liter).
For the determination of heart NA content, we removed the
rat hearts rapidly with thiobutabarbital anesthesia (see below),
quick-froze them on dry ice, and homogenized them in icecold
0.3 N perchloric acid containing 0.1% ascorbic acid [211. After
centrifugation, the supernatant was used for radioenzymatic
determination of NA content [18]; the sediment protein concen-
tration was analyzed colorimetrically.
For a microscopical demonstration of sympathetic nerve
fibers in standardized sites of the left ventricle, we induced
glyoxylic acid to fluorescence according to the de Ia Torre and
Surgeon method (22).
Reactivity of vascular smooth muscle to NA. After anesthe-
sia with thiobutabarbital (mactin; 50 mg/kg i.p.), the rats were
prepared for hindlimb perfusion according to the method of
Folkow et al [23]. The hindlimbs were perfused at a constant
temperature (37° C) and at pH 7.4 with an oxygenated Tyrode's
solution (95% 02/5% C02) containing 2% (w/v) of an artificial
colloid (Ficoll 70®, Pharmacia Fine Chemicals). Because the
flow was kept at a constant rate (10 ml/min/lOO g tissue),
changes in perfusion pressure, as measured via a T-tube,
directly reflect changes in vascular resistance [24]. Response
curves of the cumulative dosage to NA were established by
perfusion with NA concentrations varying from 108 to i04 M
perfusate. Perfusion at a given concentration continued until a
plateau was reached; this level usually required up to 5 mm.
The experiment was begun by measuring the flow resistance at
maximal vasidilatation (zero NA). The dosage-response curve
to arginine vasopressin (Ferring Company, Kid, Federal Re-
public of Germany) was obtained by perfusing with 4 to 400 x
l0 M perfusate. To avoid tachyphylaxis, we increased the
concentration stepwise in 1-mm intervals. Dosage-response
curves to potassium chloride were obtained in rats pretreated
with phenoxybenzamine (5 mg/kg i.v.) by a stepwise replace-
ment of sodium in the perfusion solution with potassium in 2-
mm intervals from 4 x l0 to 140 x l0 M. Maximum
contraction was achieved with BaCI2 (20 x l0 M).
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Table 1. Plasma concentrations of catecholamines in subtotally
nephrectomized rats (NX) and in sham-operated, control rats (CO)
CO NX
Noradrenaline, pg/mi 184 16 242 22b
Adrenaline, pg/mi 38 9 32 6
Dopamine pg/mi 115 18 71 20
The number of animals in each group was 9.
b p < 0.05
Reactivity of isolated, aortic strips to NA. Thoracic aortae of
NX and CO rats were taken out; adventitial tissue was re-
moved; helical strips (2 mm width, 2 cm length) were cut and
suspended in a 10-mi organ bath containing a standard medium
of the following composition (l0 M: NaC1 128, KCI 4.7, MgCI2
1,2, CaC12 2.5, NaHCO3 11.9, NaH2PO4 1.2, and glucose 5.5).
The bath fluid was maintained at 37° C and continuously
bubbled with a gas mixture of 95% oxygen and 5% carbon
dioxide. The strips were mounted in the bath at an initial
passive tension of 1.2 mN (milli-Newton) and were allowed to
equilibrate for at least 2 hr. Following this period, the initial
load was not readjusted but it remained identical in NX (0.64
0.135 mN) and CO (0.69 0.095 mN). Changes in tension were
measured isometrically, using Grass® FT.03 force transducers,
and, after amplification, recorded on Heath® strip-chart record-
ers. To establish cumulative dosage-response curves for NA,
the organ bath concentration of NA was raised stepwise from
10- 10 to 10 M by adding minute volumes of NA stock
solutions. Details of the experimental procedure used have
been described elsewhere [25].
Statistical analysis. The results in the tables and figures are
given as mean SEM. The significance of differences between
the experimental and the control groups was assessed by
Wilcoxon's test for random samples or the Kruskal-Wallis test.
Results
Description of the model. At the end of the experiment, 35
days after induction of uremia, CO animals (N = 9) and NX
animals (N = 9) did not differ significantly with respect to body
wt (CO 366 4.7 g; NX 358 3.8 g); plasma sodium chloride
(CO 142 0.7 m'vi NX 142 0.2); plasma potassium (4.0 0.2
mM NX 4.3 0.1);plasma calcium (2.55 0.05 mM; NX 2.60
0.05); but differed significantly with respect to plasma creati-
nine (CO 0.47 0.04 mg/dl; NX 1.06 0.05 mg/dl; P < 0.01).
Systolic BP in a light ether anesthesia was 116 2.9 mm Hg in
CO (N = 16) and 124 2.9 mm Hg in NX (N = 16). In a similar
fashion, mean intra-arterial BP measured while the rats were in
a resting but awakened condition, was slightly, but not signifi-
cantly, elevated (CO 105 5.6mm Hg; NX 112 4.7). Heart
weight was significantly higher in NX animals (CO 967 22 mg;
NX 1.071 13mg; P <0.05).
Plasma catecholamines and uptake for NA. As indicated in
Table 1, NA levels, but not adrenaline and dopamine levels,
were significantly elevated in the plasma of NX animals, In
parallel with the diminution of neuronal uptake of NA, signifi-
cantly less deaminated metabolites were released from the
hearts of NX animals. The release of 0-methylated metabolites
was identical in CO and NX animals, suggesting the same
extraneuronal metabolism (Table 2).
NA concentration was lower in the heart of uremic animals
(CO 16.4 2.4 ng NA/mg protein; NX 9.7 1.7; N = 10 per
group; P < 0.05), but NA content per heart was not significantly
different (CO 644 75 ng/heart; NX 575 80). When evaluated
qualitatively by fluorescence microscopy, a rarification of
nerve fiber density was not observed, but the individual fibers
appeared thinner and exhibited less intense fluorescence. Rep-
resentative examples are shown in Figure 1.
Vascular reactivity to NA and other pressor agents in NX.
The dosage-response relationship between NA and vascular
resistance in the isolated perfused hindlimb of chronically
uremic rats was examined in five independent experiments.
Figure 2 gives one typical example. Flow resistance was not
different in CO and NX animals at maximal dilatation (no NA)
and maximal contraction (l0 moles NA/I). The dosage-
response curve of the NX animals was shifted to the right, that
is, uremic animals showed a diminished responsiveness to
submaximal doses of NA. In the experiment shown in Figure 2,
the ED50 was 2.68 0.18 x l0_6 M in CO animals and 4.28
0.37 in NX animals (N = 9) (P < 0.01).
Such a diminished responsiveness was not observed when
the hindlimbs of chronically uremic rats were perfused with
arginine vasopressin (AVP) as shown in Figure 3. The ED50 für
AVP was 18.8 0.5 x l0- M in CO animals (N = 9) and 19.7
1.7 in NX animals (N = 9). The difference was not significant.
The effect of potassium chloride on resistance development
in the hindlimb of chronically uremic rats is depicted in Figure
4. At a potassium chloride concentration greater than 80 x l0
M, a significantly increased development of resistance was
observed in chronically uremic rats. A similarly increased
responsiveness was observed with BaCl2 perfusion.
Reactivity of aortic strips to NA in NX. The dosage-response
curve for NA in isolated, aortic strips shows a diminished force
generation at low NA concentrations and increased force
generation at high NA concentrations in uremic animals (Fig.
5). The ED20, as an index of threshold sensitivity, was signifi-
cantly (P<0.05) higher in NX animals (CO 1.35 0.22 ><
M; NX 2.25 0.24).
Vascular reactivity to NA in binephrectomized or bilateral
(x1O°) NX. As shown in Figure 6, the dosage-response curve
to NA in the isolated hindlimb of acutely uremic animals, that is,
48 hr after bilateral NX, shifted to the left, in contrast to what
was observed in chronically uremic animals (Fig. 2). As in NX,
a difference between CO and NX animals was not observed at
maximal dilatation (no NA) and maximal contraction (l0-
moles NA/liter). The ED50 was 2.86 0.10 >< 106 M in CO
animals (N =9) and 1.88 0.14 in NX animals (N = 9) (P <
0.01).
Effects of parathyroidectomy and pharmacological interven-
tions on vascular reactivity to NA (Table 3). Vascular respon-
siveness was identical in uremic animals with parathyroidecto-
my, prior to the induction of uremia, and parathyroid-intact
uremic animals.
The blockade of neuronal NA uptake by the addition of
cocaine (30 X 10—6 M) to the perfusion medium caused a
significant shift to the left of the dosage-response curve in both
CO and NX animals. However, the diminished responsiveness
of NX animals was still present despite the cocaine blockade.
Similarly, the addition of propranolol (l0 M) to the perfu-
sion medium also caused a shift of the dosage-response curve to
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Table 2. Uptake and metabolism of noradrenaline in the isolated, perfused heart of uremic animals'
Neuronal uptake Extraneuronal uptake
CO NXCO NX
Noradrenaline uptake, 85.1 13.5 50.9 545b 34.2 7.45 46.7 3.25
pmoles/min/heart
Release of deaminated metabolites, 25.7 2.90 11.2 3.lOa 1.29 1.60 2.48 1.70c
pmoles/minlheart
Release of O-methylated metabolites, —0.40 0.95 —2.45 1.04 6.53 0.64 6.80 0.92
pmoleslminl heart
a Neuronal and extraneuronal uptake of noradrenaline and release of deaminated and 0-methylated metabolites were measured in hearts of
subtotally nephrectomized rats (NX) and of sham-operated, control rats (CO). The number of animals per group was 9. Neuronal uptake and
metabolism are given as the difference before and after blockade with cocaine (30 x 10-6 M). Extraneuronal uptake and metabolism is given as the
difference before and after the additional blockade with corticosterone (100 x lO6 M).
b P < 0.05.
P <0.01.
Fig. 1. Adrenergic nerve fibers in the apex of the
left ventricle A in subtotally nephrectomized and
B in sham-operated, control rats examined by the
glyoxylic, acid-induced, fluorescence method. In
uremic rats, the innervation pattern was un-
changed, but adrenergic fibers were thinner as
compared to the control rats.
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Fig. 3. Dosage-response curve to arginine-vasopressin in the isolated
perfused hindlimb preparation of subtotally nephrectomized rats (NX,
0) and of sham-operated, control rats (GO, •). The number of rats in
each groups was 9. Ordinate is the same as in Fig. 2. There was no
significant difference of ED50 as described in Results.
the left both in CO and in NX animals. Again, the diminished
responsiveness of NX animals was demonstrable despite a beta
blockade.
Pretreatment of animals with indomethacin (2 x I mg/kg/day
subcutaneously for 7 days) caused a significant increase of
vascular responsiveness to NA in NX animals. The ED50 for
indomethacin treated NX and CO animals was not significantly
different.
Discussion
The information on the responsiveness of vascular and non-
vascular tissues to catecholamines in uremia is still controver-
sial [1—131. Clinical studies on cardiovascular actions of cate-
cholamines in uremia are of limited value because in uremic
patients indirect non-invasive procedures must be used and
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Fig. 4. Dosage-response curve to potassium chloride in the isolated-
perfusedhindlimb preparation of 16 subtotally nephrectomized (NX. 0)
rats and of 18 sham-operated control rats (CO. 5). Maximum contrac-
tion was achieved with BaCl2. Ordinate is the same as in Fig. 2.
Significant difference between nephrectomized and control rats for KCI
(above 80 x lO M) and BaCI2 (P < 0.01).
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Fig. 5. Dosage-response curve to noradrenaline of helical strips of
thoracic aortae of 11 subtally nephrectomized (NX, 0) rats and of 12
sham-operated control (GO, 5) rats. Response (ordinate) is expressed
as changes in tension (mN). ED20 was significantly higher in uremic rats
as described under Results.
baroreceptor reflexes and cardiovascular counter-regulation are
not blocked. Uremic patients respond to NA with an increase in
BP [10] and show an appropriate reflex response to orthostasis
[121. Consequently, many authors assume that sympathetic
reactivity is unchanged in uremia [121. Some clinical evidence,
however, is consistent with diminished responsiveness. In the
2 - X i0
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NX,o
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I I I
0.1 1 10 0-
20 60
100
Noradrenaline (10 M)
Fig. 2. Dosage-response curve to noradrenaline in the isolated, per-
fushed hindlimb preparation of subtotally-nephrectomized (NX, 0) and
of sham-operated, control rats (GO, 5). The number of rats in each
group was 9. Response (ordinate) is given as the increase in vascular
resistance which was calculated as the ratio of recorded increase in
perfusion pressure and perfusate flow which was kept constant. Re-
sponses are given as mean SEM. ED50 of uremic rats was higher as
described in Results.
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2.33
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0.06
(8)
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2.97 0.13
1.04 0.04
(8)d
(9)d
Control
Propranolol
3.43
2.52
0.44
0.19
(8)
(8)
5.55 0.64
3.45 0.28
(lO)C
(1O)c
Control
Indomethacin
1.95
2.13
0.10
0.14
(8)
(10)
2.53 0.10
1.97 0.12
(l0)c
(9)
a Cocaine (30 x 10-6 M perfusate) and propranolol (1 x l0 M were
added to the perfusion medium. Rats were pretreated with indometh-
acm (2 X I mg/kg/day).
N represents the number of animals per group.
P < 0.05 NX vs. CO.
P < 0.01 NX vs. CO.
Abbreviations as used are defined: PT. parathyroid intact: PTX,
parathyroidectomy.
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Fig. 6. Dosa ge-response curve to noradrenaline in the isolated per-
fused hindlimb preparation of acutely (48 hr) binephrectomized (NX, 0)
and sham-operated control rats (CO, •). Each group contained 9
animals. Response (ordinate) is given as the increase in vascular
resistance as described in Figure 2. The ED50 of uremic rats was
significantly lower as described in Results.
study of Nies, Robertson, and Stone [11]. although riot men-
tioned by the authors, the NA dose for a given pressor response
was greater in uremic subjects than in controls. Furthermore, in
uremic patients, Romoffet al [13] found an inadequate response
of BP and heart rate to orthostasis despite a marked increment
in plasma NA.
In one previous experimental study. change in the pressor
response to one dose of NA was not observed in pithed, uremic
rats after a cocaine blockade [26]. Complete dosage-response
curves, however, were not established.
In our experimental study in chronically uremic rats, the
isolated perfused hindlimb was used as an accepted in vitro
model for the response of resistance vessels to pressor agents
[23]. With this protocol, diminished responsiveness to NA in
uremia could be clearly documented. An artificial medium of
perfusion with physiological salt concentrations and colloid was
used instead of blood. This medium was chosen because it
permits one to directly study agonist-end-organ-interaction in a
system which excludes the influence of other humoral factors,
for example, release of pressor peptides, amines, circulating
prostaglandins, uptake of NA by blood cells, and so forth, that
may be observed when blood is used for perfusion. Humoral
factors that might influence sympathetic activity in vivo [27]
cannot be detected with this model. It is unknown whether or
not NA was released at the synapsis and added to the perfusion
medium act on the same receptor. This caveat must be kept in
mind when one extrapolates from perfusion experiments to
sympathetic nerve action in vivo.
Although the mechanism of diminished NA responsiveness
could not be firmly established in our study, a number of
experiments were performed to exclude artifacts and study
possible mechanisms. In our uremic rats, BP was not signifi-
cantly elevated. Structural changes of the resistance vessels
play a role in altering vascular NA response in various models
of hypertension [23, 28, 29]. A change of vessel geometry can
definitely be excluded as the cause of diminished vascular
reactivity in the described experiments. Resistance at maximal
vasodilatation and maximal contraction are indices which have
been shown to reflect structural changes of the blood vessel
wall [23]. Both parameters were not abnormal in uremic rats.
Additional support for diminished NA responsiveness comes
from the study with aortic strips. In this model, most method-
ological problems of the hindlimb preparation are avoided. Still,
an increased threshold for NA was observed, reflecting dimin-
ished NA sensitivity. The increased, maximal force generation
with NA in aortic strips, in contrast to hindlimb resistance
vessels, was not further investigated. It may be analogous to the
known difference of response between elastic and resistance
vessels to hypertension [28, 30].
An impaired force generating ability of the vessel wall
contractile apparatus is unlikely because in uremic rats the
response to other pressor agents was unchanged and vascular
—' constriction was not diminished (and even increased) upon
100 depolarization with potassium chloride or exposure to BaCl2.
Circulating NA levels were elevated in rats with chronic
experimental uremia in agreement with previous clinical obser-
vations [7—9]. Rat plasma catecholamine concentrations, as
described in our study, were lower than previously reported
[311 but in agreement with more recent data [32—34]. In addi-
tion, confirming previous findings of Hennemann et al [26],
both the neuronal uptake and metabolism of NA were found to
be diminished in the hearts of uremic rats. To the extent that
changes in the heart reflect changes in other sympathetically
innervated organs, this finding suggests that elevated circulat-
ing NA levels in uremic animals, and presumably also in uremic
patients, are due to diminished elimination of NA. If we assume
that the uptake of NA is also reduced in the vessel wall, as it is
in the heart, one would expect increased NA responsiveness.
However, the response of the isolated perfused hindlimb to
NA was diminished in chronically uremic rats. Alterations of
neuronal NA uptake or metabolism as the cause of diminished
sensitivity to NA are definitely excluded by the demonstration
that hyporesponsiveness to NA persisted despite a blockade of
neuronal uptake with cocaine.
Clinical evidence points to reduced sympathetic innervation
as a result of polyneuropathy in the autonomic nervous system
Table 3. Effect of parathyroidectomy and pharmacological
interventions on the dosage-response-curve of the isolated perfused
hindlimb preparation to noradrenaline in subtotally nephrectomized
(NX) and sham-operated, control rats (CO)a
E
X 1-
a,
x
0.5-
a,
0.1 10
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[2, 6, 12]. Some evidence of diminished sympathetic innerva-
tion was also found by measurement of NA content and by
fluorescence microscopy of the hearts of the uremic rats
studied. Hyporesponsiveness to NA, however, cannot be at-
tributed to sympathetic denervation because it would probably
lead to denervation supersensitivity.
In the presence of increased levels of NA in the circulation,
and possibly at the receptor site, downregulation of NA recep-
tors is one explanation for diminished NA responsiveness.
Downregulation of the receptors would be consistent with the
present results, but this problem was not examined directly.
Clinical studies point to altered beta-adrenergic response in
uremia [35]. In our study, addition of beta-adrenergic blockers
to the perfusion medium did not abolish hyporesponsiveness to
NA in uremic animals. Consequently, an altered relationship
between alpha- and beta-receptors cannot account for dimin-
ished responsiveness to NA.
Prostaglandins and particularly prostacyclin modulate NA
responsiveness at the presynaptic and postsynaptic levels in
veins, and at the post-synaptic level in arteries [36]. It has also
been described that vascular prostaglandin metabolism is ab-
normal in uremia [37, 38]; therefore, it is of note that pretreat-
ment with indomethacin (2 x 1 mg/kg/day) increased vascular
responsiveness to NA in uremic animals. By using higher doses
of indomethacin (2 x 2.5 mg/kg/day), we also observed what we
had noted previously, an increase of NA responsiveness in non-
uremic animals [39]. By using the lower dose, as we did in our
present experiment, no effect had been observed previously in
non-uremic animals. Indomethacin has several actions other
than the inhibition of cyclooxygenase [40] so that the findings
do not specifically prove that prostaglandins are responsible for
vascular subsensitivity to NA, but the observation is sufficient-
ly suggestive to warrant future studies.
The diminished response of vascular smooth muscle in ure-
mia is specific for NA because a difference of response to
arginine vasopressin was not found between uremic and control
animals. Unchanged vasopressin responsiveness, despite NA
hyporesponsiveness, is additional evidence against altered ves-
sel geometry or impaired contractile apparatus of vascular
smooth muscle.
Parathyroid hormone secretion is increased in experimental
uremia [41]. Pang et al [42] demonstrated that PTH has a direct
vasodilating action unrelated to alpha- or beta-adrenergic mech-
anisms. However, in our study, NA responsiveness was identi-
cal in parathyroid-intact NX and hypocalcemic parathyroidec-
tomized NX animals; therefore, a detailed analysis of calcium
and PTH influences on vascular responsiveness was not per-
formed. The vascular response in acute uremia, that is, the
response in rats 48 hr following bilateral nephrectomy, was
studied to investigate whether or not the uremic environment in
itself alters vascular responsiveness. Paradoxically, yet in agree-
ment with previous in vivo studies [43], increased responsiveness
was observed despite the uremic environment. The interpreta-
tion of this finding remains conjectural. It is of note, however,
that a positive inotropic effect of acute experimental uremia on
the heart was demonstrated by previous investigators [44].
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